-Live Mint Developments a part of reforms initiated after apex court’s intervention to amend Drugs and Cosmetics Act The health ministry has tightened the norms for clinical trials by making it mandatory for companies to compensate patients who may suffer injury or death while participating in the trials even if they have not been caused by the drugs being tested.   So far, the compensation has been restricted only to cases where the...

-The Hindu By opting for a U.S.-style medical care model, India is endangering its universal health coverage goal, and paving the way for a corporatised, for-profit system As India continues to debate how best to implement universal health coverage, two recent and seemingly unrelated news items need to be analysed carefully. The first one pertains to a report released earlier this year by the National Research Council and the Institute of Medicine in...

-The Economic Times Over the past 15 months, rural development minister Jairam Ramesh has made more than 150 visits to 41 of the 82 Naxal-affected districts. Emerging as the government's face in these remote areas, Ramesh talks to ET about the efforts and progress needed to contain the Maoist influence. * Fifteen months of "development" focus in the Naxal-affected areas. What's the progress? It's a mixed bag: some progress in Jharkhand, West...

-The Hoot The media welcomed the UID's promise of giving an identity to those outside the system, but has failed to track its failure to do so. On January 1, the Indian government announced roll out of its ambitious cash transfer scheme  in 20 districts of the country based on unique identification (UID), also called Aadhaar. The media, while presenting the pros and cons of cash transfer, also mentioned that...

-The Times of India MUMBAI: The Union government and regulatory bodies appear to be serious in ending the pharma-doctor nexus and curb unethical marketing practices. In its latest effort, the Medical Council of India has directed Doctors, hospitals and medical colleges to prescribe generic medicines as far as possible. Generic medicines are more affordable versions of branded medicines sold by companies. In its directive dated January 21 to the principals of medical...